Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Insulin degludec
Jun 02, 2020
Novo Nordisk to present new data at the 80th Annual American Diabetes Association Scientific Sessions
Feb 27, 2020
FDA Clears InPen Diabetes Management System for Fixed Dosing and Meal Estimation
Jan 23, 2019
Xultophy® now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes
Oct 01, 2018
Health Canada approves TRESIBA® for children with Type 1 diabetes
Sep 21, 2018
Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus
Jun 25, 2018
Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec
Jun 23, 2018
Tresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence study
Jun 23, 2018
Tresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo® in real-world evidence study
Jun 23, 2018
Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications
Jun 18, 2018
Novo Nordisk to present 39 abstracts at the 78th Annual American Diabetes Association Scientific Sessions
Apr 18, 2018
Xultophy® approved in Canada for the treatment of adults with type 2 diabetes
Mar 26, 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba® label
Jan 25, 2018
Data Demonstrate Hygieia d-Nav® Insulin Guidance Service Generates Substantial Cost Savings By Optimizing Insulin and The Use of Glycemic Medications Among People with Type 2 Diabetes
Dec 04, 2017
Sanofi's Toujeo® met main objective in head-to-head study versus insulin degludec
Nov 30, 2017
Switching to Toujeo® in a real-world setting produced a similar number of severe low blood sugar events as insulin degludec
Aug 28, 2017
Health Canada Approves Tresiba®, a New Basal Insulin for Type 1 and 2 Diabetes
Jun 12, 2017
Tresiba® demonstrated no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial
Jun 12, 2017
New, Long-Acting Insulin Therapy Demonstrates Cardiovascular Safety and Reduces the Risk of Severe Hypoglycemia
Jun 10, 2017
Xultophy® 100/3.6 demonstrated similar A1C reductions with significantly lower rates of hypoglycemia and a decrease in weight vs basal-bolus therapy
Jun 10, 2017
In Senior Adults Treated with Basal Insulin, Switching to Sanofi's Toujeo® Halved Hypoglycemia Risk
Latest News
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
Apr 26, 2024
Parsec’s Double Award Win Showcases Dedication to Customers and Manufacturing Expertise
Apr 25, 2024
FCA Packaging Invests in Greentree Packaging and Lumber
Apr 25, 2024
TriMas Packaging Receives Silver Award as Strategic Supplier
Apr 25, 2024
Effigis Geo-Solutions Inc. and Provincial Pole Specialists, Inc. Are Rebranded to Osmose Utilities Services...
Apr 25, 2024
Materion Corporation to Announce First Quarter 2024 Financial Results on May 1
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
DC Load Simulates AI Microprocessors Power Draw Below 0.8VDC
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events